These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10177544)

  • 1. Improving the process of medication budget forecasting.
    Vermeulen LC; Marnocha RM; Thielke TS
    Pharm Pract Manag Q; 1998 Apr; 18(1):72-80. PubMed ID: 10177544
    [No Abstract]   [Full Text] [Related]  

  • 2. Exponential smoothing method for forecasting drug expenditures.
    D'Sa MM; Nakagawa RS; Hill DS; Tan JK
    Am J Hosp Pharm; 1994 Oct; 51(20):2581-8. PubMed ID: 7847421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Projecting future drug expenditures--1993.
    Santell JP
    Am J Hosp Pharm; 1993 Jan; 50(1):71-7. PubMed ID: 8427283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projecting future drug expenditures--1994.
    Santell JP
    Am J Hosp Pharm; 1994 Jan; 51(2):177-87. PubMed ID: 8160668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rising cost of pharmaceuticals: a director of pharmacy's perspective.
    Pierpaoli PG
    Am J Hosp Pharm; 1993 Aug; 50(8 Suppl 4):S6-8. PubMed ID: 8213862
    [No Abstract]   [Full Text] [Related]  

  • 6. As hospital drug budgets soar, pharmacy's role is being rewritten.
    Lumsdon K
    Hospitals; 1992 May; 66(10):34, 36, 38-40. PubMed ID: 1577448
    [No Abstract]   [Full Text] [Related]  

  • 7. One hospital's success with medication budget control.
    McLean W; Simon V
    Leadersh Health Serv; 1994; 3(2):6-10. PubMed ID: 10133642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost comparison of Canadian and U.S. hospital pharmacy departments.
    Weil TP
    Hosp Pharm; 1994 Jan; 29(1):15-7, 20-3. PubMed ID: 10131492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving budget control: a case study.
    Karali J
    Hosp Cost Manag Account; 1993 May; 5(2):1-8. PubMed ID: 10125473
    [No Abstract]   [Full Text] [Related]  

  • 10. Marketplace. How drug company mergers affect HMOs and hospitals.
    Moskowitz DB
    Faulkner Grays Med Health; 1997 Jun; 51(23):suppl 2 p.. PubMed ID: 10167794
    [No Abstract]   [Full Text] [Related]  

  • 11. Business issues in the pharmacy. Managing pharmacy costs.
    Serb C
    Hosp Health Netw; 2005 May; 79(5):57-62, 2. PubMed ID: 15971799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of pharmacy personnel to positively impact hospital finances.
    Hutchinson RA; Hatoum HT; Kolinski R; Riley DW
    Hosp Formul; 1989 Aug; 24(8):450, 453. PubMed ID: 10294357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotechnology drugs create new maze of concerns for hospitals.
    Lumsdon K
    Hospitals; 1991 Dec; 65(23):32, 34-5. PubMed ID: 1937456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drugs blast budgets. Patients benefit; hospital pharmacies weigh options.
    Hensley S
    Mod Healthc; 1998 Jun; 28(23):36. PubMed ID: 10184954
    [No Abstract]   [Full Text] [Related]  

  • 15. National drug bill to continue rising by 14%-18%.
    Manag Care; 2003 Jul; 12(7):52. PubMed ID: 12891957
    [No Abstract]   [Full Text] [Related]  

  • 16. Projecting future drug expenditures--2006.
    Hoffman JM; Shah ND; Vermeulen LC; Schumock GT; Grim P; Hunkler RJ; Hontz KM
    Am J Health Syst Pharm; 2006 Jan; 63(2):123-38. PubMed ID: 16390926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Projecting future drug expenditures--2004.
    Hoffman JM; Shah ND; Vermeulen LC; Hunkler RJ; Hontz KM
    Am J Health Syst Pharm; 2004 Jan; 61(2):145-58. PubMed ID: 14750400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug cost increases are generated by the 50 top selling pharmaceuticals.
    Health Care Strateg Manage; 2001 Jun; 19(6):14-5, 1. PubMed ID: 11409091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generic pharmaceutical prices continue their decline in prices from last year.
    Hosp Mater Manage; 1996 Feb; 21(2):1, 12-3. PubMed ID: 10154299
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotech drugs: high costs becoming hard to swallow.
    Wagner M
    Mod Healthc; 1992 Jan; 22(2):24-5, 28-9. PubMed ID: 10115803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.